Expand FATE Menu
FATE MENU

FATE Latest Press Releases

-- December 8, 2025 --

Fate Therapeutics Presents Updated Phase 1 Clinical Data of FT819 Off-the-shelf CAR T-cell Product Candidate for Systemic Lupus Erythematosus and Preclinical Advances in Next-Generation Off-the-Shelf CAR T-cell Programs Globe Newswire 8:00 AM

-- November 25, 2025 --

Fate Therapeutics to Present at Piper Sandler 37th Annual Healthcare Conference Globe Newswire 8:00 AM

-- November 13, 2025 --

Fate Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates Globe Newswire 8:30 AM

-- November 4, 2025 --

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:01 PM

-- October 26, 2025 --

Fate Therapeutics Presents New Clinical Data at ACR Convergence 2025 Demonstrating Immune Remodeling and Durable Responses in Patients with Systemic Lupus Erythematosus Treated with FT819 Off-the-Shelf CAR T-Cell Therapy Globe Newswire 11:30 AM

-- October 14, 2025 --

Fate Therapeutics Expands Leadership Team with Appointment of Kamal Adawi as Chief Financial Officer Globe Newswire 8:00 AM

-- October 2, 2025 --

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:01 PM

-- September 3, 2025 --

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:01 PM

-- August 25, 2025 --

Fate Therapeutics to Present at Upcoming Investor Conferences Globe Newswire 8:00 AM

-- August 12, 2025 --

Fate Therapeutics Reports Second Quarter 2025 Financial Results and Business Updates Globe Newswire 4:01 PM

-- August 5, 2025 --

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:01 PM
Market Data Delayed 15 Minutes